Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003-2017).

Bo PanYing XuYidong ZhouRu YaoXingtong ZhouYali XuXinyu RenMengsu XiaoQingli ZhuLingyan KongFeng MaoYan LinXiaohui ZhangSongjie ShenQiang Sun

Published in: Breast cancer research and treatment (2022)

Screen-detected bilateral NPBC including SynBiNPBC and MetaBiNPBC showed good prognosis as UniNPBC so that the therapy of BiNPBC could be de-escalated and optimized according to UniNPBC. Contrarily, screen-detected ipsilateral NPBC with contralateral palpable BC [(N + Contra) PBC] manifested unfavorable survival worse than UniNPBC and synchronous (N + Contra) PBC had the worst survival among all subgroups, implying that these were actually bilateral interval BC and required intensified treatment.

Keyphrases

high throughput
case report
free survival
healthcare
polycystic ovary syndrome
emergency department
stem cells
breast cancer risk
metabolic syndrome
pregnancy outcomes
replacement therapy
single cell
electronic health record
insulin resistance
smoking cessation
chemotherapy induced